A Study of Physical Activity in Cancer Survivors

Sponsor
Mayo Clinic (Other)
Overall Status
Recruiting
CT.gov ID
NCT05988892
Collaborator
(none)
50
1
5.3
9.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if increasing physical activity (PA) will increase physical functioning, as measured by cardiovascular endurance, muscular strength, and balance in underserved adult cancer survivors > 60 years of age and/or those of any age residing at a rural address. Also, to determine if increasing PA will increase quality of life (QOL), as measured by physical functioning and fatigue, in underserved cancer survivors >60 years of age and/or those of any age residing at a rural address.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Physical Activity

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Improving Physical Activity in Rural and Older Cancer Survivors
Actual Study Start Date :
Jun 23, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Community Oncology patients entering cancer survivorship

Adult Mayo Clinic Health System Northwest Wisconsin Community Oncology patients entering cancer survivorship (completed initial treatment) Underserved: Older (≥60 years), lower-income, rural, ethnic/racial minority, lacking access/available/acceptable forms of exercise programs

Behavioral: Physical Activity
Use Exercise to increase physical activity (PA), as measured by cardiovascular endurance, muscular strength, and balance in underserved cancer survivors >60 years of age and/or those of any age residing at a rural address and to increase quality of life (QOL), as measured by physical functioning and fatigue, in underserved cancer survivors >60 years of age and/or those of any age residing at a rural address.

Outcome Measures

Primary Outcome Measures

  1. Change in physical functioning using Short Physical Performance Battery [Baseline; 12 weeks]

    Change in physical functioning based on improvement in endurance, strength, and balance assessed using Short Physical Performance Battery (SPPB) pre- and post-12-week exercise intervention.

  2. Change in Quality of Life (QOL) using Patient-Reported Outcomes Measurement Information System (PROMIS) [Baseline; 12 weeks]

    QOL evaluated based on physical functioning and fatigue, assessed using Patient-Reported Outcomes Measurement Information System (PROMIS) pre- and post-12-week exercise intervention.

  3. Change in satisfaction using a 5-point Likert scale [Baseline; 12 weeks]

    Satisfaction assessed using a 5-point Likert scale following 12-week exercise intervention and participant-reporting likelihood of recommending program.

  4. Rate of adherence to program based on participation in virtual exercise sessions [Baseline; 12 weeks]

    Adherence evaluated based on participation in virtual exercise sessions during 12-week exercise intervention.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult, cancer survivors (no active disease) at Mayo Clinic Health System (MCHS) in Northwest Wisconsin (NWWI)

  • Any stage cancer

  • Age ≥60 years residing at any address, or ≥18 years residing at a rural address (as defined by Rural America, census.gov)

  • Completed active treatment of surgery, (neo)adjuvant chemotherapy, and/or (neo) adjuvant radiation. Patients receiving adjuvant endocrine therapy, targeted therapy, or immunotherapy therapies are eligible.

  • Ownership of a computer/tablet/smartphone with internet access.

  • Willingness and ability to attend study visits.

  • Must be able to complete semi-tandem (10 seconds), side-by-side tandem (10 seconds and SPPB Score of >6 to qualify for virtual exercise.

  • Must be ambulatory without the use of assisted device(s).

Exclusion Criteria:
  • Receiving surgery, (neo)adjuvant chemotherapy, (neo) adjuvant radiation, palliative treatment

  • Are already performing >150 minutes/week of moderate activity or 75 min/week of vigorous physical activity

  • Cancer-free for greater than 5 years

  • Unable to complete weekly interventions/exercise due to traveling or unable to be active for more than 7 consecutive days.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Health System-Eau Claire Clinic Eau Claire Wisconsin United States 54701

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Kaye T. Sturz, APRN, CNP, Mayo Clinic Health System in Eau Claire

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT05988892
Other Study ID Numbers:
  • 23-001462
  • NCI-2023-05387
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 15, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mayo Clinic

Study Results

No Results Posted as of Aug 15, 2023